Order Article Reprints

Nörz D, Grunwald M, Tang HT, Weinschenk C, Günther T, Robitaille A, Giersch K, Fischer N, Grundhoff A, Aepfelbacher M, et al. Clinical Evaluation of a Fully-Automated High-Throughput Multiplex Screening-Assay to Detect and Differentiate the SARS-CoV-2 B.1.1.529 (Omicron) and B.1.617.2 (Delta) Lineage Variants. Viruses. 2022; 14(3):608. https://doi.org/10.3390/v14030608

Nörz, Dominik, Moritz Grunwald, Hui Ting Tang, Celine Weinschenk, Thomas Günther, Alexis Robitaille, Katja Giersch, Nicole Fischer, Adam Grundhoff, Martin Aepfelbacher, and et al. 2022. "Clinical Evaluation of a Fully-Automated High-Throughput Multiplex Screening-Assay to Detect and Differentiate the SARS-CoV-2 B.1.1.529 (Omicron) and B.1.617.2 (Delta) Lineage Variants" Viruses 14, no. 3: 608. https://doi.org/10.3390/v14030608

Nörz, D., Grunwald, M., Tang, H. T., Weinschenk, C., Günther, T., Robitaille, A., Giersch, K., Fischer, N., Grundhoff, A., Aepfelbacher, M., Pfefferle, S., & Lütgehetmann, M. (2022). Clinical Evaluation of a Fully-Automated High-Throughput Multiplex Screening-Assay to Detect and Differentiate the SARS-CoV-2 B.1.1.529 (Omicron) and B.1.617.2 (Delta) Lineage Variants. Viruses, 14(3), 608. https://doi.org/10.3390/v14030608